Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
AXM Pharma Inc. (AXMP) had Normalized Pre-Tax Income of $-0.01M for the most recently reported fiscal year, ending 2017-12-31.
| Income Statement Financials | |
-- |
|
$-0.01M |
|
-- |
|
-- |
|
$0.01M |
|
$-0.01M |
|
$-0.00M |
|
$-0.01M |
|
|
Normalized Pre-Tax Income |
$-0.01M |
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
$-0.01M |
|
158.60M |
|
158.60M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
$0.03M |
|
-- |
|
-- |
|
$0.03M |
|
$-0.03M |
|
$-0.03M |
|
$-0.03M |
|
158.60M |
|
| Cash Flow Statement Financials | |
$0.00M |
|
-- |
|
$0.01M |
|
-- |
|
-- |
|
$0.01M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-0.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
26.26% |
|
28.94% |
|
-- |
|
28.94% |
|
$-0.00 |
|
$0.00 |
|
$0.00 |
|